Selected publications
-
Ibrutinib unmasks critical role of bruton tyrosine kinase in primary CNS lymphoma.
Cancer Discovery.
2017
Academic Article
GET IT
Times cited: 68 -
Increased risk of arterial thromboembolism in older men with breast cancer.
Breast Cancer Research and Treatment.
2017
Academic Article
GET IT
Times cited: 3 -
Risk of Arterial Thromboembolism in Patients With Cancer.
Journal of the American College of Cardiology.
2017
Academic Article
GET IT
Times cited: 80 -
T-cell invigoration to tumour burden ratio associated with anti-PD-1 response.
Nature.
2017
Academic Article
GET IT
Times cited: 322 -
Patterns and Timing of Initial Relapse in Pathologic Stage II Melanoma Patients.
Annals of Surgical Oncology.
2017
Academic Article
GET IT
Times cited: 10 -
Elevated Blood Neutrophil-to-Lymphocyte Ratio: A Readily Available Biomarker Associated with Death due to Disease in High Risk Nonmetastatic Melanoma.
Annals of Surgical Oncology.
2017
Academic Article
GET IT
Times cited: 14 -
Neutrophil to Lymphocyte Ratio is Associated With Outcome During Ipilimumab Treatment.
EBioMedicine.
2017
Academic Article
GET IT
Times cited: 32 -
Frequency and Predictors of Acute Hospitalization Before Death in Patients With Glioblastoma.
Journal of Pain and Symptom Management.
2017
Academic Article
GET IT
Times cited: 6 -
Clinical features and response to systemic therapy in a historical cohort of advanced or unresectable mucosal melanoma.
Melanoma Research.
2016
Academic Article
GET IT
Times cited: 9 -
Physician-driven variation in nonrecommended services among older adults diagnosed with cancer.
JAMA Internal Medicine.
2016
Academic Article
GET IT
Times cited: 19 -
A peripheral blood biomarker estimates probability of survival: The neutrophil-lymphocyte ratio in noncancer patients.
Biomarkers in Medicine.
2016
Academic Article
GET IT
Times cited: 7 -
Evaluating cancer of the central nervous system through next-generation sequencing of cerebrospinal fluid.
Journal of Clinical Oncology.
2016
Academic Article
GET IT
Times cited: 90 -
A phase 2 trial of everolimus and pasireotide long-acting release in patients with metastatic uveal melanoma.
Melanoma Research.
2016
Academic Article
GET IT
Times cited: 4 -
Radiotherapy and temozolomide for anaplastic astrocytic gliomas.
Journal of Neuro-Oncology.
2015
Academic Article
GET IT
Times cited: 3 -
R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma.
Blood.
2015
Academic Article
GET IT
Times cited: 118 -
Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma.
Clinical Cancer Research.
2014
Academic Article
GET IT
Times cited: 42 -
Pretreatment serum VEGF is associated with clinical response and overall survival in advanced melanoma patients treated with ipilimumab.
Cancer Immunology Research.
2014
Academic Article
GET IT
Times cited: 80 -
Recursive partitioning analysis of prognostic variables in newly diagnosed anaplastic oligodendroglial tumors.
Neuro-Oncology.
2014
Academic Article
GET IT
Times cited: 9 -
Immunologic responses to xenogeneic tyrosinase DNA vaccine administered by electroporation in patients with malignant melanoma.
Journal for ImmunoTherapy of Cancer.
2013
Academic Article
GET IT
Times cited: 24 - Likelihood Modelling: A Statistical Perspective on Gene Expression Data Analysis. 2005 Chapter GET IT
-
Vaccination with a bivalent G
M2 and GD2 ganglioside conjugate vaccine: A trial comparing doses of GD2 -keyhole limpet hemocyanin. Clinical Cancer Research. 2000 Academic Article GET IT
Times cited: 44